Payer Perspectives on Drug Delivery

This podcast features a panel discussion with payers, investors and consultants about how they approach decisions to cover new medications and the role novel delivery approaches play in that decision-making from the 2024 PODD: Partnership Opportunities in Drug Delivery Conference.The panelists discuss the growing number of self-insured employers that are considering restricting drugs based on cost alone, the future of weight loss drugs and GLP-1s and potential factors influencing market access for gene therapies for more common conditions.To learn more about the PODD conference, please visit Drug-Delivery.org.